ATE127926T1 - Verfahren zum nachweis von entzündungen. - Google Patents

Verfahren zum nachweis von entzündungen.

Info

Publication number
ATE127926T1
ATE127926T1 AT92106707T AT92106707T ATE127926T1 AT E127926 T1 ATE127926 T1 AT E127926T1 AT 92106707 T AT92106707 T AT 92106707T AT 92106707 T AT92106707 T AT 92106707T AT E127926 T1 ATE127926 T1 AT E127926T1
Authority
AT
Austria
Prior art keywords
cicam
amount
inflammation
patient
sample
Prior art date
Application number
AT92106707T
Other languages
English (en)
Inventor
Robert Rothlein
Steven D Marlin
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE127926T1 publication Critical patent/ATE127926T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Rehabilitation Therapy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Drying Of Semiconductors (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fire-Detection Mechanisms (AREA)
AT92106707T 1991-05-03 1992-04-17 Verfahren zum nachweis von entzündungen. ATE127926T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/695,173 US5223396A (en) 1991-05-03 1991-05-03 Method for detecting organ transplant rejection

Publications (1)

Publication Number Publication Date
ATE127926T1 true ATE127926T1 (de) 1995-09-15

Family

ID=24791925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92106707T ATE127926T1 (de) 1991-05-03 1992-04-17 Verfahren zum nachweis von entzündungen.

Country Status (12)

Country Link
US (3) US5223396A (de)
EP (1) EP0512301B1 (de)
JP (1) JP3226323B2 (de)
AT (1) ATE127926T1 (de)
AU (1) AU664367B2 (de)
CA (1) CA2067916C (de)
DE (1) DE69204732T2 (de)
DK (1) DK0512301T3 (de)
ES (1) ES2077909T3 (de)
GR (1) GR3018162T3 (de)
NZ (1) NZ242603A (de)
ZA (1) ZA923167B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874563A (en) * 1984-03-15 1989-10-17 Basf Structural Materials Inc. Process for preparing tows from composite fiber blends
US4818318A (en) * 1984-03-15 1989-04-04 Hoechst Celanese Corp. Method of forming composite fiber blends
US4871491A (en) * 1984-03-15 1989-10-03 Basf Structural Materials Inc. Process for preparing composite articles from composite fiber blends
US5284931A (en) 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US5324510A (en) * 1989-09-01 1994-06-28 Boehringer Ingelheim Pharmaceuticals, Inc. Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
EP0468257B1 (de) * 1990-07-20 1999-09-01 Bayer Corporation Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5223396A (en) * 1991-05-03 1993-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Method for detecting organ transplant rejection
DK145393D0 (da) * 1993-12-23 1993-12-23 Stig Haunsoe Proteinmarkoerer til forudsigelse af akut allotransplantatafstoedning
DE19631192C2 (de) * 1996-08-03 1998-09-10 Hellmut Dr Augustin Verfahren zur Früherkennung gestosegefährdeter schwangerer Frauen
JP2001511889A (ja) * 1997-01-24 2001-08-14 センター フォー ブラッド リサーチ インコーポレイテッド 動物における体重に関連する病気の診断及び治療方法
WO1999027964A1 (en) * 1997-12-01 1999-06-10 Cfy Biomedicals, Inc. Multivalent recombinant antibodies for treating hrv infections
DE19845617A1 (de) * 1998-03-02 1999-09-30 Johannes Eichenauer Verfahren zur Kontrolle inflammatorischer Reaktionen medizinischer Behandlungen
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
US6150121A (en) * 1999-02-16 2000-11-21 Wisconsin Alumni Research Foundation Assessing immunological state of transplant recipients
AU2001230920A1 (en) * 2000-01-14 2001-07-24 Genentech Inc. Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
CA2454358A1 (en) 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
US8026343B2 (en) 2008-08-08 2011-09-27 Dinona Inc. Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof
KR101434029B1 (ko) * 2012-09-14 2014-08-26 서울대학교산학협력단 Ｉｃａｍ－1에 대한 항체 및 그 용도
CN103698537A (zh) * 2014-01-06 2014-04-02 天津医科大学总医院 定量检测人血清可溶性细胞间粘附分子-1的化学发光免疫分析试剂盒及检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ES2080044T3 (es) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular y sus ligandos de fijacion.
ATE114972T1 (de) * 1987-11-02 1994-12-15 Baylor College Medicine Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen.
US5235049A (en) * 1989-01-24 1993-08-10 Molecular Therapeutics, Inc. Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
HU217792B (hu) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
GB9009549D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
US5223396A (en) * 1991-05-03 1993-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Method for detecting organ transplant rejection

Also Published As

Publication number Publication date
HK1003124A1 (en) 1998-10-09
AU1598692A (en) 1992-11-05
EP0512301B1 (de) 1995-09-13
CA2067916C (en) 2004-04-20
NZ242603A (en) 1993-07-27
DK0512301T3 (da) 1996-01-22
JPH05149948A (ja) 1993-06-15
US5472849A (en) 1995-12-05
JP3226323B2 (ja) 2001-11-05
CA2067916A1 (en) 1992-11-04
US5354659A (en) 1994-10-11
DE69204732T2 (de) 1996-03-21
DE69204732D1 (de) 1995-10-19
EP0512301A1 (de) 1992-11-11
ES2077909T3 (es) 1995-12-01
GR3018162T3 (en) 1996-02-29
ZA923167B (en) 1993-03-31
US5223396A (en) 1993-06-29
AU664367B2 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
ATE127926T1 (de) Verfahren zum nachweis von entzündungen.
DK0779984T3 (da) Optisk læsbar strimmel til analytpåvisning med en standard på strimlen
DE69115462D1 (de) Überwachung eines in einem Wasser-Kühlsystem zirkulierenden Behandlungsmittels
DE69706594D1 (de) Reagenzteststreifen zum Nachweis von Glukose im Blut
FI885115A7 (fi) Laite kaasujen tunnistamiseksi ja pitoisuuden mittaamiseksi sekä menetelmä kaasujen tunnistamiseksi
FI940911A7 (fi) Menetelmä ja laite juoksevaa väliainetta sisältävän näytteen mittamist a varten
DE69712139D1 (de) Vorrichtung zum Messen der Konzentration eines Analyten mit Ferndosierung
FR2503368B1 (fr) Procede et dispositif de mesure des constituants du sang
FR2605402B1 (fr) Dispositif de la detection de la presence de givre et/ou de mesure de l'epaisseur de givre par ultra-sons et sonde de givrage utilisable dans un tel dispositif
PL315493A1 (en) Multilayer reagent test strip with direct indication of concentration and method of measuring analyte concentration
DK0618449T3 (da) Fremgangsmåde til bestemmelse af hæmoglobin-additionsprodukter
ATE195807T1 (de) Test zum nachweis von proteinen in einer biologischen probe
CA2149903A1 (en) Use of capillary electrophoresis for quantitating the concentration of protein components and of the total protein in fluids
JPS57129697A (en) Method and tester for measuring glucose concentration
NO983126L (no) Fremgangsmåte og anordning for å måle farge og/eller partikler i et fluid
ATE202848T1 (de) Verfahren zum nachweis und/oder quantifikation eines haptens in einer homogenen phase und vorrichtung dafür
FI910549A7 (fi) Menetelmä ja laite nestenäytteen fluoresenssin määrittämiseksi
ES8700440A1 (es) Metodo y equipo para detectar la presencia de aminas
SE9300231D0 (sv) Foerbaettrad metod foer brytningsindexdetektion i vaetska
SE9802852L (sv) Fluidumavkänningsanordning och förfarande speciellt för användning i mjölkningsmaskiner
FI915285A0 (fi) Menetelmä näytteiden mittaamiseksi nestetuikelaskimella ja nestetuikelaskin
EP0737863A4 (de) Verfahren zum nachweis von blutkomponenten und kit dafür
JPS5764146A (en) Automatic detecting method for interval of measuring sample of densitometer
BE880302A (fr) Dispositif permettant de realiser le pontage des joints ou fissures en une seule operation et son procede d'application
SE9403597D0 (sv) Förfarande och anordning vid en gelelektroforesapparat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification